Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance

The aim of the present study was to explore the potential impact of upfront metastases-directed therapy (MDT) in terms of prolongation of castration-sensitive phase in a series of oligorecurrent castration-sensitive prostate cancer (PC) patients. The present article is a multicenter retrospective st...

Descripción completa

Detalles Bibliográficos
Autores principales: Triggiani, Luca, Mazzola, Rosario, Tomasini, Davide, Bruni, Alessio, Alicino, Giulia, Matrone, Fabio, Bortolus, Roberto, Francolini, Giulio, Detti, Beatrice, Magli, Alessandro, Bonù, Marco Lorenzo, Ingrosso, Gianluca, Lancia, Andrea, Trippa, Fabio, Maranzano, Ernesto, Franzese, Ciro, Ghirardelli, Paolo, Vavassori, Vittorio, Scorsetti, Marta, Alongi, Filippo, Magrini, Stefano Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131275/
https://www.ncbi.nlm.nih.gov/pubmed/34008151
http://dx.doi.org/10.1007/s12032-021-01518-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131275/
https://www.ncbi.nlm.nih.gov/pubmed/34008151
http://dx.doi.org/10.1007/s12032-021-01518-6

Ejemplares similares